The role of cytokeratin 19 levels in the determination of endometriosis stages

References

• Bulun SE. Mechanisms of disease endometriosis. N Engl J Med. 2009;360(3):268–279.
   PubMed Web of Science ®Google Scholar
• Pabalan N, Jarjanazi H, Christofolini DM, et al. Association of the intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms with endometriosis: a systematic reviewand meta-analysis. Arch Gynecol Obstet. 2015;292(4):843–851.
   PubMed Web of Science ®Google Scholar
• Aghajanpour L, Mashayekhi F, Rajaei F. Intercellular adhesion molecule-1 (ICAM-1) gene polymorphism and endometriosis in Northern Iran. Arch Gynecol Obstet. 2011;283(5):1035–1039.
   PubMed Web of Science ®Google Scholar
• Sharpe Timms KL. Endometrial anomalies in women with endometriosis. Ann NY Acad Sci. 2001;943:131–147.
   PubMed Web of Science ®Google Scholar
• Olive DL, Schwartz LB. Endometriosis. N Engl J Med. 1993;328(24):1759–1769.
   PubMed Web of Science ®Google Scholar
• Heidemann LN, Hartwell D, Heidemann CH, et al. The relation between endometriosis and ovarian cancer - a review. Acta Obstet Gynecol Scand. 2014;93(1):20–31.
   PubMed Web of Science ®Google Scholar
• Cho S, Mutlu L, Grechukhina O, et al. Circulating microRNAs as potential biomarkers for endometriosis. Fertil Steril. 2015;103(5):1252–1260.e1.
   PubMed Web of Science ®Google Scholar
• Van den Brûle FA, Fernandez PL, Buicu C, et al. Differential expression of galectin-1 and galectin-3 during first trimester human embryogenesis. Dev Dyn. 1997;209(4):399–405.
   PubMed Web of Science ®Google Scholar
• Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31(1):11e24.
   Web of Science ®Google Scholar
• Nakata B, Ogawa Y, Ishikawa T, et al. Serum CYFRA21-1 I a one of the most reliable tumor marker for breast carcinoma. Cancer. 2000;89(6):1285e90–1281290.
   Web of Science ®Google Scholar
• Uenishi T, Kubo S, Hirohashi K, et al. Cytokeratin 19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer. Br J Cancer. 2003;88(12):1894e9–181899.
   Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Cooper D, Schermer A, Sun TT. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Lab Invest. 1985;52(3):243–256.
   PubMed Web of Science ®Google Scholar
• Baloch ZW, Abraham S, Roberts S, et al. Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility. Hum Pathol. 1999;30(10):1166–1171.
   PubMed Web of Science ®Google Scholar
• Rorive S, Eddafali B, Fernandez S, et al. Changes in galectin-7 and cytokeratin 19 expression during the progression of malignancy in thyroid tumors: diagnostic and biological implications. Mod Pathol. 2002;15(12):1294–1301.
   PubMed Web of Science ®Google Scholar
• Berezowski K, Stastny JF, Kornstein MJ. Cytokeratins 7 and 20 and carcinoembryonic antigen in colonic carcinoma. Mod Pathol. 1996;9(4):426–429.
   PubMed Web of Science ®Google Scholar
• Han AC, Duszak R. Coexpression of cytokeratins 7 and 20 confirms urothelial carcinoma presenting as an intrarenal tumor. Cancer. 1999;86(11):2327–2330.
   PubMed Web of Science ®Google Scholar
• Tot T. Patterns of distribution of cytokeratin 20 and 7 in special types of invasive breast carcinoma – a study of 123 cases. Ann Diagn Pathol. 1999;3:350–356.
   PubMedGoogle Scholar
• Moll R, Lowe A, Laufer J, et al. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992;140(2):427–447.
   PubMed Web of Science ®Google Scholar
• Lam KY, Loke SL, Shen XC, et al. Cytokeratin expression in non-neoplastic oesophageal epithelium and squamous cell carcinomas of the oesophagus. Virchows Arch. 1995;426(4):345–349.
   PubMedGoogle Scholar
• Khurana KK, Truong LD, LiVolsi VA, et al. Cytokeratin 19 immunolocalization in cell block preparation of thyroid aspirates. An adjunct to fine-needle aspiration diagnosis of papillary thyroid carcinoma. Arch Pathol Lab Med. 2003;127(5):579–583.
   PubMed Web of Science ®Google Scholar
• Cheung CC, Ezzat S, Freeman JL, et al. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol. 2001;14(4):338–342.
   PubMed Web of Science ®Google Scholar
• Miettinen M, Kovatich AJ, Karkkainen P. Keratin subsets in papillary and follicular thyroid lesions. A parafin section analysis with diagnostic implications. Virchows Arch. 1997;431(6):407–413.
   PubMed Web of Science ®Google Scholar
• Fonseca E, Nesland J, Hoie J, et al. Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial- type cytokeratins. Virchows Arch. 1997;430(3):239–245.
   PubMed Web of Science ®Google Scholar
• Raphael SJ, Apel RL, Asa SL. Brief report: detection of high- molecular-weight cytokeratinsin neoplastic and non-neoplastic thyroid tumors using microwave antigen retrieval. Mod Pathol. 1995;8(8):870–872.
   PubMed Web of Science ®Google Scholar
• Pujol JL, Molinier O, Ebert W, et al. CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of metaanalysis in 2063 patients. Br J Cancer. 2004;90(11):2097e105–20972105.
   Web of Science ®Google Scholar
• Giovanella L, Treglia G, Verburg FA, et al. Serum cytokeratin 19 fragments: a dedifferentiation marker in advanced thyroid cancer. Eur J Endocrinol. 2012;167(6):793–797.
   PubMed Web of Science ®Google Scholar
• Yan HJ, Wang RB, Zhu KL, et al. Cytokeratin 19 fragment antigen 21-1 as an independent predictor for definitive chemoradiotherapy sensitivity in esophageal squamous cell carcinoma. Chin Med J (Engl). 2012;125(8):1410–1415.
   PubMed Web of Science ®Google Scholar
• Holdenrieder S, Stieber P, Liska V, et al. Cytokeratin serum biomarkers in patients with colorectal cancer. Anticancer Res. 2012;32:1971e6.
   Web of Science ®Google Scholar
• Zhu WQ, Yu JM, Sun XD, et al. Serum CYFRA21-1 as a prognostic marker for patients with undifferentiated nasopharyngeal carcinoma. Biomarkers. 2010;15(7):602e7–607.
   Web of Science ®Google Scholar
• Sheng X, Du X, Zhang X, et al. Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels. Croat Med J. 2009;50(5):455e64–464.
   Web of Science ®Google Scholar
• Zachariah R, Schmid S, Radpour R, et al. Circulating cell-free DNA as a potential biomarker for minimal and mild endometriosis. Reprod Bio Med Online. 2009;18(3):407–411.
   PubMed Web of Science ®Google Scholar
• Rizner TL noninvasive biomarkers of endometriosis: myth or reality? Expert Rev Mol Diagn. 2014;14:365–385.
   PubMed Web of Science ®Google Scholar
• Bartek J, Bartkova J, Taylor-Papadimitriou J, et al. Differential expression of keratin 19 in normal human epithelial tissues revealed by monospecific monoclonal antibodies. Histochem J. 1986;18(10):565–575.
   PubMedGoogle Scholar
• Tokushige N, Markham R, Crossett B, et al. Discovery of a novel biomarker in the urine in women with endometriosis. Fertil Steril. 2011;95(1):46–49.
   PubMed Web of Science ®Google Scholar
• Lessey BA, Savaris RF, Ali S, et al. Diagnostic accuracy of urinary cytokeratin19 fragment for endometriosis. Reprod Sci. 2015;22(5):551–555.
   PubMed Web of Science ®Google Scholar